Pengaruh Profitabilitas, Ukuran Perusahaan, Dan Financial Distress Terhadap Audit Delay Pada Perusahaan Sub-Sektor Pharmaceuticals & Health Care Research Yang Terdaftar Di Bursa Efek Indonesia Periode 2021–2025

Abstract

This research is motivated by fluctuations in the timeliness of financial reporting during
the transition period post-COVID-19 pandemic, which posed unique operational and
regulatory challenges for the healthcare sector. This study aims to examine and analyze
the effects of Profitability, Firm Size, and Financial Distress on Audit Delay in healthcare
companies listed on the Indonesia Stock Exchange (IDX) for the 2021–2025 period. A
quantitative associative approach was employed to measure the cause-and-effect
relationships between variables. Using the purposive sampling method, a final sample of
11 companies was obtained over a five-year observation period, resulting in a total panel
data of 55 observations. Based on model specification tests, the Common Effect Model
(CEM). The partial test results (t-test) indicate that profitability has a negative and
significant effect on audit delay, with a t-statistic of -5,477536 and a probability value of
0.0000. Conversely, company size and financial distress are shown to have no significant
effect on audit delay, with respective t-statistics and probability values of 0,662978 and
0,5103, and 0,329597 and 0,7431. Simultaneously (F-test), all independent variables
significantly affect audit delay, with an Adjusted R-squared value of 40,89%, while the
remaining 59,11% is influenced by other factors outside this research model.